Blog Article
GLP-1 Medications: What Employers Need to Know About Direct-to-Consumer Pricing Trends
Pharmacy Benefits Consulting
2026 Trends in Pharmacy Benefits Management
What employers need to know about drug pricing, reforms, GLP-1 strategy, biosimilars, and regulatory shifts shaping pharmacy spend in 2026 and beyond.
Why This Guide Matters?
Pharmacy Benefits Are Facing Unprecedented Disruption
Federal policy shifts, PBM reform, GLP-1 demand, and biosimilar expansion are reshaping the pharmacy landscape. In this guide, OneDigital's pharmacy benefit experts break down the most critical pharmacy trends employers must understand to:
- Control rising pharmacy costs
- Improve transparency and governance
- Protect plan sustainability
- Make informed and strategic benefit design decisions
What's Inside the Guide
In this resource, you’ll explore:
- Maximum Fair Prices (MFPs) and Medicare Drug Price Negotiation impacts
- Most-Favored-Nation (MFN) pricing and downstream effects on commercial plans
- Direct-to-consumer drug programs and the launch of TrumpRx
- Federal and state-level PBM reform efforts
- Transparency, spread pricing bans, and ownership restrictions
- FDA biosimilar interchangeability guidance updates
- Anticipated GLP-1 pricing, access, and utilization trends
- Key biosimilar launches and generic drug opportunities
- Therapeutic areas with significant FDA activity to monitor
- How these trends may affect formulary strategy, rebates, and plan design
- Where employers can reduce risk while maintaining access and outcomes
Get the Insights You Need for Employee Benefits Planning
Understanding pharmacy trends early gives employers a strategic advantage. Access the guide to see how evolving drug pricing policies, GLP-1 utilization, biosimilars, and PBM reform may impact your plan, and what to do next.
$467 Billion Saved
Generics and biosimilars saved employers $467 billion in 2024.Knowing what's coming off patent, and when, can mean significant savings for your plan.
Access the Guide
17% of Pharmacy Spend
GLP-1s now account for 17% of total pharmacy spend, up from just 9% in 2022.Demand is accelerating. Is your benefits strategy keeping pace?
Access the Guide
Frequently Asked Questions
A complimentary thought-leadership guide that outlines the most important pharmacy benefit, drug pricing, and regulatory trends employers should understand when planning for 2026 and beyond.
Pharmacy spend continues to be one of the fastest-growing components of total healthcare costs. With evolving drug pricing policies, PBM reform efforts, GLP-1 utilization growth, and biosimilar expansion, employers need proactive strategies to manage cost, access, and risk.
This guide is designed for employers, HR and benefits leaders, finance and risk leaders, and executive teams responsible for healthcare cost management and benefits strategy.
No. This guide is provided at no cost by OneDigital as an educational resource for employers.
You’ll receive immediate access to the full PDF guide, along with the option to connect with a OneDigital pharmacy expert to discuss how these trends may impact your organization’s pharmacy strategy.
Download the Guide
